Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $88.2000 (-0.36%) ($86.7700 - $88.4350) on Tue. Jan. 14, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.11% (three month average) | RSI | 37 | Latest Price | $88.2000(-0.36%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.2% a day on average for past five trading days. | Weekly Trend | ABBV declines -0.2% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(63%) SPLV(53%) VYM(53%) DIA(52%) IVE(51%) | Factors Impacting ABBV price | ABBV will decline at least -0.555% in a week (0% probabilities). VIXM(-36%) VXX(-14%) TLT(-14%) UUP(-0%) IGOV(2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.555% (StdDev 1.11%) | Hourly BBV | -0.9 () | Intraday Trend | 1.3% | | | |
|
Resistance Level | $89.24 | 5 Day Moving Average | $89.1(-1.01%) | 10 Day Moving Average | $89.05(-0.95%) | 20 Day Moving Average | $89.24(-1.17%) | To recent high | -2.3% | To recent low | 19.6% | Market Cap | $155.61b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |